Research Article

Clear Lensectomy with Hydrus Stent in Black and Afro-Latino Patients: A 1-Year Retrospective Study

Table 3

Intraocular pressure and number of medications at preoperative and follow-up visits for patients with mild, moderate, and advanced glaucoma who underwent clear lensectomy in combination with Hydrus microstent implant.

TimepointMild glaucoma (N = 68)Moderate glaucoma (N = 40)Advanced glaucoma (N = 26)
IOP (mean ± SD; mmHg) valueNumber of medications (mean ± SD) valueIOP (mean ± SD; mmHg) valueNumber of medications (mean ± SD) valueIOP (mean ± SD; mmHg) valueNumber of medications (mean ± SD) value

Preoperative15 ± 4.12.1 ± 1.1813.7 ± 3.92.6 ± 1.414.1 ± 3.63.2 ± 1.5
Postoperative day 111.9 ± 4.9<0.00111.5 ± 4.30.0212.6 ± 5.10.22
1 month15 ± 5.5>0.990.11 ± 0.61<0.00114.2 ± 4.70.600.03 ± 0.16<0.00114.3 ± 3.40.830.3 ± 1.0<0.001
3 months13.5 ± 3.00.0160.28 ± 0.88<0.00112.5 ± 2.60.110.35 ± 0.91<0.00113.1 ± 2.80.260.71 ± 1.1<0.001
6 months13.6 ± 3.10.020.41 ± 1.12<0.00112.4 ± 2.30.080.24 ± 0.8<0.00112.9 ± 2.80.180.72 ± 1.1<0.001
1 year14.3 ± 3.10.260.40 ± 1.05<0.00113.3 ± 2.40.580.2 ± 0.72<0.00113.7 ± 3.80.690.88 ± 1.3<0.001

IOP, intraocular pressure; N, number of patients; SD, standard deviation. values are statistically significant.